Related Experiment Video
Updated: Apr 21, 2026

14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
8.8K
Renal protective effect of sirtuin 1
Yi-jun Dong1, Nian Liu2, Zhi Xiao3
1Department of Nephrology, First Hospital of Jilin University, Changchun 130021, China.
Journal of Diabetes Research
|November 12, 2014
Summary
Silent information regulator 1 (SIRT1) deacetylase activity is crucial for cellular metabolism and survival. SIRT1 activation shows therapeutic potential for kidney diseases, including diabetic nephropathy.
Area of Science:
- Biochemistry
- Molecular Biology
- Nephrology
Background:
- Silent information regulator 2 (Sir2) proteins are NAD(+)-dependent deacetylases.
- SIRT1, a mammalian homolog of Sir2, plays roles in energy metabolism, redox state, and cellular survival pathways.
- SIRT1 activity is implicated in age-related diseases like cancer, neurodegeneration, diabetes, and cardiovascular disease.
Purpose of the Study:
- To review the protective functions of sirtuins, particularly SIRT1.
- To examine the role of SIRT1 in the development of various kidney diseases.
- To highlight SIRT1 activation as a potential therapeutic strategy for chronic kidney disease.
Main Methods:
- Literature review of previous studies on sirtuins and kidney disease.
- Analysis of SIRT1's involvement in renal cell apoptosis, inflammation, and fibrosis.
- Exploration of SIRT1's role in specific kidney conditions such as diabetic nephropathy, acute renal injury, chronic kidney disease, and lupus nephritis.
Main Results:
- SIRT1 deacetylates target proteins, influencing cellular metabolism and survival.
- Inhibition of renal cell apoptosis, inflammation, and fibrosis by SIRT1 suggests protective effects in the kidneys.
- Evidence supports SIRT1's involvement in the pathogenesis of multiple kidney diseases.
Conclusions:
- Sirtuins, especially SIRT1, possess significant protective functions in the kidneys.
- SIRT1 activation represents a promising therapeutic avenue for patients with chronic kidney disease and diabetic nephropathy.
- Further research into SIRT1's role can advance treatment strategies for diverse renal pathologies.